Menu
PacPremier
Magic Hour
Montecito
SoCal Gas
Loading...
You are here:  Home  >  'Novartis'
Latest

Amgen, Novartis sue each other over migraine drug Aimovig

By   /  Friday, April 5th, 2019  /  Biotech, Central Coast Health Watch, East Ventura County, Latest news, Law  /  Comments Off on Amgen, Novartis sue each other over migraine drug Aimovig

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen gets FDA approval for migraine drug Aimovig

By   /  Thursday, May 17th, 2018  /  Central Coast Health Watch, East Ventura County, Latest news, Technology  /  Comments Off on Amgen gets FDA approval for migraine drug Aimovig

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen clinical trial shows promising results for migraine drug Aimovig

By   /  Tuesday, April 17th, 2018  /  Central Coast Health Watch, East Ventura County, Latest news, Technology  /  Comments Off on Amgen clinical trial shows promising results for migraine drug Aimovig

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

FDA gives big win to Amgen in biosimilars race

By   /  Friday, September 30th, 2016  /  Central Coast Health Watch, East Ventura County, Latest news  /  Comments Off on FDA gives big win to Amgen in biosimilars race

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen announces positive results for migraine drug

By   /  Thursday, September 29th, 2016  /  Central Coast Health Watch, Latest news  /  Comments Off on Amgen announces positive results for migraine drug

Thousand Oaks-based biotech giant Amgen announced positive data from a phase 3 study of a new migraine drug co-developed with competitor Novartis. Amgen said in a news release that, after 12 weeks, Erenumab showed a significant reduction in monthly migraine days in patients with episodic migraines treated with Erenumab compared with a placebo. In the Read More →

Read More →
Latest

FDA approves biosimilar of Amgen’s Enbrel

By   /  Tuesday, August 30th, 2016  /  Central Coast Health Watch, Latest news, Tri-County Public Companies  /  Comments Off on FDA approves biosimilar of Amgen’s Enbrel

The U.S. Food and Drug Administration formally approved a competing biosimilar of Amgen’s top-selling drug Enbrel on Aug. 30. Made by Switzerland-based Novartis, Erelzi mimics the effects of Enbrel. Enbrel, which was first approved in 1998, is approved to treat rheumatoid arthritis and other conditions by decreasing the amount of a protein produced by the Read More →

Read More →
Latest

Silence is deafening when new drugs are not approved

By   /  Friday, August 5th, 2016  /  Columns, Latest news, Technology  /  Comments Off on Silence is deafening when new drugs are not approved

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →